Oxytetracycline


Curated chemical-disease associations from CTD
Disease IDDisease nameReference
MESH:D000419 Albuminuria PMID:7364640
MESH:D001002 Anuria PMID:7364640
MESH:D001919 Bradycardia PMID:7364640
MESH:D002780 Cholestasis, Intrahepatic PMID:15963097; PMID:8479374
MESH:D003128 Coma PMID:598213
MESH:D003221 Confusion PMID:598213
MESH:D003681 Dehydration PMID:8905581
MESH:D003967 Diarrhea PMID:7364640; PMID:8905581
MESH:D006029 Glycosuria PMID:7364640
MESH:D006212 Hallucinations PMID:598213
MESH:D006417 Hematuria PMID:7364640
MESH:D007410 Intestinal Diseases PMID:37027337
MESH:D009056 Mouth Abnormalities PMID:17328645
MESH:D009401 Nephrosis PMID:8905581
MESH:D009846 Oliguria PMID:7364640
MESH:D014839 Vomiting PMID:7364640; PMID:8905581
MESH:D017449 Dermatitis, Allergic Contact PMID:8462297
MESH:D017484 Dermatitis, Phototoxic PMID:29248593
MESH:D053099 Azotemia PMID:5140825; PMID:5411600; PMID:8905581
MESH:D054559 Hyperphosphatemia PMID:8905581
MESH:D058186 Acute Kidney Injury PMID:5413699; PMID:7364640
MESH:D062787 Drug Overdose PMID:5413699; PMID:7364640
MESH:D064420 Drug-Related Side Effects and Adverse Reactions PMID:7364640
MESH:D064806 Dysbiosis PMID:37027337

DISCLAIMER

We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.